|
May 12, 2026
|
Nkarta Reports First Quarter 2026 Financial Results and Corporate Highlights
|
|
|
Apr 15, 2026
|
Nkarta Announces FDA Agreement on Outpatient Dosing of NKX019 in Autoimmune Disease, Expanding Access to Community Rheumatology Centers
|
|
|
Apr 09, 2026
|
Nkarta to Participate in Needham Virtual Healthcare Conference
|
|
|
Mar 25, 2026
|
Nkarta Reports Fourth Quarter and Full Year 2025 Financial Results and Corporate Highlights
|
|
|
Feb 27, 2026
|
Nkarta to Participate in March Investor Conferences
|
|
